2.5 ML linvoseltamab-gcpt 2 MG/ML Injection
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
2.5 ML linvoseltamab-gcpt 2 MG/ML Injection
2 MG/ML · Injection · injection
A form of linvoseltamab-gcpt →
2.5 ML linvoseltamab-gcpt 2 MG/ML Injection — Other monoclonal antibodies and antibody drug conjugates. Strength, form, class, interactions & more.
Active ingredient
Classification
Other monoclonal antibodies and antibody drug conjugatesBispecific B Cell Maturation Antigen-directed CD3 T Cell Engager
Drug interactions
Linvoseltamab-gcpt may increase the exposure of certain CYP substrates, leading to a higher risk of adverse reactions.
- moderateCYP substrates — increased risk of adverse reactions
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication